Hb F synthesis in sickle cell anaemia: a comparison of Saudi Arab cases with those of African origin
- PMID: 6158984
- DOI: 10.1111/j.1365-2141.1980.tb07163.x
Hb F synthesis in sickle cell anaemia: a comparison of Saudi Arab cases with those of African origin
Abstract
Fetal haemoglobin (Hb F) synthesis has been studied in 22 cases of sickle cell anemia (SS) from Saudi Arabia and compared with an equal number of cases of African origin. Among the Saudi Arabs gamma chain synthesis ranged from 4.0% to 19.9% of the total non-alpha chain synthesis (mean 8.1%) while the corresponding range for the Negro cases was < 0.3% to 4.6% (mean 1.7%). In both groups the peripheral blood Hb F level was on average 3--4 times higher than the proportion synthesized, indicating that the selective survival of Hb F containing cells (F cells) was an important factor in determining the final Hb F levels. Among the Saudi Arab cases there was a significant negative correlation between the degree of F cell enrichment and either the Hb F level of the percentage gamma chain synthesis. No such correlation was observed among the Negro cases. A high proportion of the cases in both groups were carriers of alpha thalassaemia in addition to SS, but no effect of alpha thalassaemia on Hb F production was observed.
Similar articles
-
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.Br J Haematol. 1978 Nov;40(3):415-29. doi: 10.1111/j.1365-2141.1978.tb05813.x. Br J Haematol. 1978. PMID: 749927
-
Fetal haemoglobin level--effect of gender, age and haemoglobin disorders.Mol Cell Biochem. 1994 Jun 29;135(2):181-6. doi: 10.1007/BF00926521. Mol Cell Biochem. 1994. PMID: 7530809
-
Effect of alpha thalassaemia, G-6-PD deficiency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia.Trop Geogr Med. 1990 Jul;42(3):241-7. Trop Geogr Med. 1990. PMID: 1705730
-
Hb F in sickle cell anemia.Experientia. 1993 Jan 15;49(1):16-27. doi: 10.1007/BF01928784. Experientia. 1993. PMID: 7679078 Review.
-
Fetal haemoglobin in homozygous sickle cell disease.Clin Haematol. 1975 Feb;4(1):109-22. Clin Haematol. 1975. PMID: 1102178 Review.
Cited by
-
Evaluation of haematological findings in 50 Bahraini patients with sickle cell disease and in some of their parents.J Med Genet. 1985 Aug;22(4):293-5. doi: 10.1136/jmg.22.4.293. J Med Genet. 1985. PMID: 4045957 Free PMC article.
-
Therapeutic manipulation of globin gene expression in the hemoglobinopathies.J Natl Med Assoc. 1986 Jul;78(7):599-600. J Natl Med Assoc. 1986. PMID: 3746928 Free PMC article. No abstract available.
-
Recombinant human hemoglobins designed for gene therapy of sickle cell disease.Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9852-6. doi: 10.1073/pnas.91.21.9852. Proc Natl Acad Sci U S A. 1994. PMID: 7937904 Free PMC article.
-
Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.Experientia. 1993 Feb 15;49(2):133-7. doi: 10.1007/BF01989417. Experientia. 1993. PMID: 7680003 Review.
-
Regulation of fetal hemoglobin synthesis in sickle cell anemia.Trans Am Clin Climatol Assoc. 1987;98:21-8. Trans Am Clin Climatol Assoc. 1987. PMID: 2441510 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical